Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.

Stensland M, Bru KF, Austdal M, Dahl IH, Jonsdottir K, Lende TH, Heimvik C, Elve I, Omdal R, van der Giezen M, Kvivik I, Tangeland B, Davidsen L, Hashemi M, Cais A, van Dijk KJ, Seyoum Y, Blåfjelldal V, Sola ST, Papadopoulos A, Kiriakidou N, Ioakeimidis I, Diou C, Sarafis I, Delopoulos A, Janssen EAM, Gilje B, Tjensvoll K

Open source

DOI
10.1007/s10238-026-02073-y
Published
2026 Feb 8
Container
Clinical and experimental medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10238-026-02073-y,
  title = {Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.},
  author = {Stensland M and Bru KF and Austdal M and Dahl IH and Jonsdottir K and Lende TH and Heimvik C and Elve I and Omdal R and van der Giezen M and Kvivik I and Tangeland B and Davidsen L and Hashemi M and Cais A and van Dijk KJ and Seyoum Y and Blåfjelldal V and Sola ST and Papadopoulos A and Kiriakidou N and Ioakeimidis I and Diou C and Sarafis I and Delopoulos A and Janssen EAM and Gilje B and Tjensvoll K},
  year = {2026},
  journal = {Clinical and experimental medicine},
  doi = {10.1007/s10238-026-02073-y},
  url = {https://doi.org/10.1007/s10238-026-02073-y}
}

RIS

TY  - JOUR
TI  - Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.
AU  - Stensland M
AU  - Bru KF
AU  - Austdal M
AU  - Dahl IH
AU  - Jonsdottir K
AU  - Lende TH
AU  - Heimvik C
AU  - Elve I
AU  - Omdal R
AU  - van der Giezen M
AU  - Kvivik I
AU  - Tangeland B
AU  - Davidsen L
AU  - Hashemi M
AU  - Cais A
AU  - van Dijk KJ
AU  - Seyoum Y
AU  - Blåfjelldal V
AU  - Sola ST
AU  - Papadopoulos A
AU  - Kiriakidou N
AU  - Ioakeimidis I
AU  - Diou C
AU  - Sarafis I
AU  - Delopoulos A
AU  - Janssen EAM
AU  - Gilje B
AU  - Tjensvoll K
PY  - 2026
JO  - Clinical and experimental medicine
DO  - 10.1007/s10238-026-02073-y
UR  - https://doi.org/10.1007/s10238-026-02073-y
ER  - 

APA

M, S., KF, B., M, A., IH, D., K, J., TH, L., C, H., I, E., R, O., M, V. D. G., I, K., B, T., L, D., M, H., A, C., KJ, V. D., Y, S., V, B., ST, S., A, P., N, K., I, I., C, D., I, S., A, D., EAM, J., B, G., & K, T. (2026). Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.. Clinical and experimental medicine. https://doi.org/10.1007/s10238-026-02073-y

Source records